199 related articles for article (PubMed ID: 30030182)
1. Nanoparticle uptake by circulating leukocytes: A major barrier to tumor delivery.
Betker JL; Jones D; Childs CR; Helm KM; Terrell K; Nagel MA; Anchordoquy TJ
J Control Release; 2018 Sep; 286():85-93. PubMed ID: 30030182
[TBL] [Abstract][Full Text] [Related]
2. PEGylation of Carbonate Apatite Nanoparticles Prevents Opsonin Binding and Enhances Tumor Accumulation of Gemcitabine.
Mozar FS; Chowdhury EH
J Pharm Sci; 2018 Sep; 107(9):2497-2508. PubMed ID: 29883662
[TBL] [Abstract][Full Text] [Related]
3. Dense and Dynamic Polyethylene Glycol Shells Cloak Nanoparticles from Uptake by Liver Endothelial Cells for Long Blood Circulation.
Zhou H; Fan Z; Li PY; Deng J; Arhontoulis DC; Li CY; Bowne WB; Cheng H
ACS Nano; 2018 Oct; 12(10):10130-10141. PubMed ID: 30117736
[TBL] [Abstract][Full Text] [Related]
4. The Effect of Repeat Administration of Lipoplexes on Gene Delivery, Biodistribution, and Cytokine Response in Immunocompetent Tumor-Bearing Mice.
Betker JL; Anchordoquy TJ
J Pharm Sci; 2022 Jul; 111(7):1926-1936. PubMed ID: 34929156
[TBL] [Abstract][Full Text] [Related]
5. The Use of Lactose as an Alternative Coating for Nanoparticles.
Betker JL; Anchordoquy TJ
J Pharm Sci; 2020 Apr; 109(4):1573-1580. PubMed ID: 32004536
[TBL] [Abstract][Full Text] [Related]
6. Accelerated Blood Clearance Phenomenon Reduces the Passive Targeting of PEGylated Nanoparticles in Peripheral Arterial Disease.
Im HJ; England CG; Feng L; Graves SA; Hernandez R; Nickles RJ; Liu Z; Lee DS; Cho SY; Cai W
ACS Appl Mater Interfaces; 2016 Jul; 8(28):17955-63. PubMed ID: 27340833
[TBL] [Abstract][Full Text] [Related]
7. Application of polyglycerol coating to plasmid DNA lipoplex for the evasion of the accelerated blood clearance phenomenon in nucleic acid delivery.
Abu Lila AS; Uehara Y; Ishida T; Kiwada H
J Pharm Sci; 2014 Feb; 103(2):557-66. PubMed ID: 24347396
[TBL] [Abstract][Full Text] [Related]
8. Nonadditive Effects of Repetitive Administration of Lipoplexes in Immunocompetent Mice.
Betker JL; Anchordoquy TJ
J Pharm Sci; 2017 Mar; 106(3):872-881. PubMed ID: 27887890
[TBL] [Abstract][Full Text] [Related]
9. Self-assembling micelle-like nanoparticles based on phospholipid-polyethyleneimine conjugates for systemic gene delivery.
Ko YT; Kale A; Hartner WC; Papahadjopoulos-Sternberg B; Torchilin VP
J Control Release; 2009 Jan; 133(2):132-8. PubMed ID: 18929605
[TBL] [Abstract][Full Text] [Related]
10. Biodistribution, pharmacokinetics, and blood compatibility of native and PEGylated tobacco mosaic virus nano-rods and -spheres in mice.
Bruckman MA; Randolph LN; VanMeter A; Hern S; Shoffstall AJ; Taurog RE; Steinmetz NF
Virology; 2014 Jan; 449():163-73. PubMed ID: 24418549
[TBL] [Abstract][Full Text] [Related]
11. Improvement of biodistribution and therapeutic index via increase of polyethylene glycol on drug-carrying liposomes in an HT-29/luc xenografted mouse model.
Chow TH; Lin YY; Hwang JJ; Wang HE; Tseng YL; Wang SJ; Liu RS; Lin WJ; Yang CS; Ting G
Anticancer Res; 2009 Jun; 29(6):2111-20. PubMed ID: 19528471
[TBL] [Abstract][Full Text] [Related]
12. PEGylation of model drug carriers enhances phagocytosis by primary human neutrophils.
Kelley WJ; Fromen CA; Lopez-Cazares G; Eniola-Adefeso O
Acta Biomater; 2018 Oct; 79():283-293. PubMed ID: 30195083
[TBL] [Abstract][Full Text] [Related]
13. Systemic delivery of siRNA to tumors using a lipid nanoparticle containing a tumor-specific cleavable PEG-lipid.
Hatakeyama H; Akita H; Ito E; Hayashi Y; Oishi M; Nagasaki Y; Danev R; Nagayama K; Kaji N; Kikuchi H; Baba Y; Harashima H
Biomaterials; 2011 Jun; 32(18):4306-16. PubMed ID: 21429576
[TBL] [Abstract][Full Text] [Related]
14. Uptake and release profiles of PEGylated liposomal doxorubicin nanoparticles: A comprehensive picture based on separate determination of encapsulated and total drug concentrations in tissues of tumor-bearing mice.
Wang H; Zheng M; Gao J; Wang J; Zhang Q; Fawcett JP; He Y; Gu J
Talanta; 2020 Feb; 208():120358. PubMed ID: 31816795
[TBL] [Abstract][Full Text] [Related]
15. The impact of PEGylation patterns on the in vivo biodistribution of mixed shell micelles.
Gao H; Liu J; Yang C; Cheng T; Chu L; Xu H; Meng A; Fan S; Shi L; Liu J
Int J Nanomedicine; 2013; 8():4229-46. PubMed ID: 24235825
[TBL] [Abstract][Full Text] [Related]
16. Characterization of long-circulating cationic nanoparticle formulations consisting of a two-stage PEGylation step for the delivery of siRNA in a breast cancer tumor model.
Ho EA; Osooly M; Strutt D; Masin D; Yang Y; Yan H; Bally M
J Pharm Sci; 2013 Jan; 102(1):227-36. PubMed ID: 23132529
[TBL] [Abstract][Full Text] [Related]
17. Distribution and Cellular Uptake of PEGylated Polymeric Particles in the Lung Towards Cell-Specific Targeted Delivery.
Shen TW; Fromen CA; Kai MP; Luft JC; Rahhal TB; Robbins GR; DeSimone JM
Pharm Res; 2015 Oct; 32(10):3248-60. PubMed ID: 26002743
[TBL] [Abstract][Full Text] [Related]
18. Impact of PEGylation on biodistribution and tumor accumulation of Lipid-Mu peptide-DNA.
Bai J; Zhou Z; Tang H; Song S; Peng J; Xu Y
J Liposome Res; 2013 Mar; 23(1):1-10. PubMed ID: 23077979
[TBL] [Abstract][Full Text] [Related]
19. The role of tissue macrophages in the induction of proinflammatory cytokine production following intravenous injection of lipoplexes.
Sakurai F; Terada T; Yasuda K; Yamashita F; Takakura Y; Hashida M
Gene Ther; 2002 Aug; 9(16):1120-6. PubMed ID: 12140741
[TBL] [Abstract][Full Text] [Related]
20. Anti-PEG antibodies alter the mobility and biodistribution of densely PEGylated nanoparticles in mucus.
Henry CE; Wang YY; Yang Q; Hoang T; Chattopadhyay S; Hoen T; Ensign LM; Nunn KL; Schroeder H; McCallen J; Moench T; Cone R; Roffler SR; Lai SK
Acta Biomater; 2016 Oct; 43():61-70. PubMed ID: 27424083
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
